✦ LIBER ✦

P135 COMPARISON OF INDUCTION AND MAINTENANCE COSTS OF INFLIXIMAB, ADALIMUMAB AND CERTOLIZUMAB PEGOL IN MANAGING CROHN'S DISEASE

✍ Scribed by S. Tan; J. Hinojosa; D. Malone; M. Brown

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit-Risk Assessment of the TNF-Antag

✍ Colombel, Jean-Frederic ;Panaccione, Remo ;Robinson, Anne ;Thakkar, Roopal ;Huan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Sa1925 Does Obesity Impact Treatment Eff

✍ Click, Benjamin; Tuskey, Anne G.; Behm, Brian W. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Su2084 Efficacy of Certolizumab Pegol In

✍ Sandborn, William J.; Younes, Ziad H.; Pierre-Louis, Bosny; D'Haens, Geert R. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 152 KB

P067 ANALYSES ON QUALITY-ADJUSTED LIFE-Y

✍ B. Feagan; S. Tan; M. Brown 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 75 KB

Clinical trial: impact of prior inflixim

✍ S. B. Hanauer; J. Panes; J.-F. Colombel; R. Bloomfield; S. Schreiber; W. J. Sand 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB

943 Impact of Certolizumab Pegol On Qual

✍ Brian Feagan; Seng Tan; Martin Brown 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 98 KB